Kerin B. Adelson, MD, on Improving End-of-Life Planning and Reducing Futile Care
2016 Quality Care SymposiumKerin B. Adelson, MD, of the Yale Cancer Center, discusses the major healthcare cost drivers at the end of life—aggressive treatments, emergency room visits, and futile care—and strategies for improving value. (Abstract 3)
Related Videos
Lawrence N. Shulman, MD, on Survival as a Measure of Quality and Advances in Therapy
Lawrence N. Shulman, MD, of the University of Pennsylvania, discusses his paper, which explores lessons learned from analyses of the National Cancer Data Base. (Abstract 173)
Allison Kurian, MD, on Assessing Quality in the Age of Precision Medicine
Allison Kurian, MD, of Stanford University School of Medicine, discusses pressing questions about the clinical utility and value of extended genomic testing and other forms of prec...
Robert Miller, MD: CancerLinQ Update
Robert Miller, MD, ASCO’S Vice President of Quality and Guidelines, discusses CancerLinQ, the “big data” technology platform, and implementation of a rapid learning system for onco...
Dawn L. Hershman, MD, on Improving Quality and Safety With Multidisciplinary Teams
Dawn L. Hershman, MD, of Columbia University Medical Center, summarizes a joint ASCO/NCI session on this important topic, including the challenges and solutions.
Lee N. Newcomer, MD, on Assessing Quality: Payer Perspective
Lee N. Newcomer, MD, of the UnitedHealth Group, gives his perspective on how to assess quality in the age of precision medicine.
